[{"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202099"], "brand_name": ["ZENATANE"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-113", "55111-135", "55111-136", "55111-137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930", "1373333", "1373335", "1373337", "1605088"], "spl_id": ["d7d883f9-7d20-2c50-8023-e661b46dcd5b"], "spl_set_id": ["27b3cf26-f22e-5b70-1c24-009933b7c6ee"], "package_ndc": ["55111-135-79", "55111-135-81", "55111-136-79", "55111-136-81", "55111-137-79", "55111-137-81", "55111-113-79", "55111-113-81", "55111-113-78"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"]}, "product_type": "Drugs", "event_id": "76539", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0507-2017", "product_description": "Zenatane (isotretinoin) capsules, 20 mg, packaged in 30-count  cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090  India, NDC 55111-136-81", "product_quantity": "12132 cartons", "reason_for_recall": "Failed dissolution specifications - low dissolution  results at S3 stage.", "recall_initiation_date": "20170215", "center_classification_date": "20170302", "termination_date": "20181219", "report_date": "20170308", "code_info": "Lot # KB50877, KB50878, Exp 11/17; KB50878, 01KB60251, Exp 3/18", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0733-2019", "product_description": "Dr. King's SafeCare Rx Repressed Sexual Issues Mind & Body, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955126027, NDC 57955-1261-2", "product_quantity": "29 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 061716B Exp. 06/19; 012517K Exp. 01/20"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0696-2019", "product_description": "Dr. King's Natural Medicine Cooling Acute Pain Relief Pure Homeopathic Cream, 3 oz. (85 g), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955400134,  NDC 57955-4001-3", "product_quantity": "12280 tubes", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060816 Exp. 06/19; 081717ZZ Exp. 08/19; 110117ZZ Exp. 11/20; 045017ZZ Exp. 04/20; 100516ZZ Exp. 06/19; 111016ZZ Exp. 11/19"}, {"status": "Completed", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68158", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1320-2014", "product_description": "Vitamin C (ascorbic acid) Injection, USP, 500 mg per 2 mL, 50 x 2 mL ampoules per box, Manufactured by: TP Drug Laboratories (1969) Co., Ltd., 98 Soi Sukhumvlt 62, Yak 1, Bangchak, Prakanong, Bangkok 10260, Thailand, Reg. No. 1 A 1557/30; UPC 8 853533 000533", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Parenteral product is sold over the counter whose labeling indicates it is to be used for the treatment of disease.", "recall_initiation_date": "20140429", "center_classification_date": "20140513", "report_date": "20140521", "code_info": "Lot #: 556273, Exp 9/25/16; 556219, Exp 8/2/16, or any other lot distributed by Flawless Beauty.", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0209-2015", "product_description": "PAPAV HCL/PHENTOL/PROSTAGL, 12mg/1mg/10mcg, injectable, 1.25 mL glass vial or 1.7 ml glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "25 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140827@30, discard date: 10/11/2014;  Lot #: 20140910@28/1.7, discard date: 10/25/2014;  Lot #: 20140917@2/1.25, discard date: 11/1/2014."}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078181"], "brand_name": ["GLIMEPIRIDE"], "generic_name": ["GLIMEPIRIDE"], "manufacturer_name": ["Northwind Pharmaceuticals, LLC"], "product_ndc": ["51655-120"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLIMEPIRIDE"], "rxcui": ["199247"], "spl_id": ["f2b3e5d4-8ae1-acfc-e053-2a95a90a4b30"], "spl_set_id": ["3e81a39a-30bb-4d6d-82e1-17d7134365be"], "package_ndc": ["51655-120-52", "51655-120-26"], "original_packager_product_ndc": ["16729-003"], "nui": ["N0000175608", "M0020795"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "unii": ["6KY687524K"]}, "product_type": "Drugs", "event_id": "91944", "recalling_firm": "Northwind Pharmaceuticals LLC", "address_1": "4838 Fletcher Ave Ste 1000", "address_2": "N/A", "postal_code": "46203-1642", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0552-2023", "product_description": "Glimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count bottles (NDC 51655-120-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.", "product_quantity": "a) 198 bottles; b) 22 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230316", "center_classification_date": "20230426", "report_date": "20230503", "code_info": "a) Lot #: F105692201, Exp. Date 09/30/2024; F105692203, Exp. Date 02/28/2025 b) Lot #: F105692202, Exp. Date 02/28/2025"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0317-2017", "product_description": "TriMix, Alprostadil/Phentolamine/Papaverine 30mcg/1mg/10mg/mL, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "5 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06022016E (07/17/2016)."}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074893"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-469", "63323-471"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859867", "859871", "1719803", "1719862"], "spl_id": ["86dff2aa-2ab3-42fc-989e-619b13ace573"], "spl_set_id": ["ca9896e0-fb2e-46a4-8700-20d144c14764"], "package_ndc": ["63323-469-01", "63323-469-05", "63323-471-01", "63323-471-05"], "is_original_packager": [true], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "73652", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0818-2016", "product_description": "Haloperidol Decanoate Injection, 50 mg/mL, 1 mL vial, Rx Only. Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-469-01.", "product_quantity": "48,210 units", "reason_for_recall": "Failed Impurities/Degradation Specifications: Firm is recalling product due to an impurity out-of-specification result.", "recall_initiation_date": "20160407", "center_classification_date": "20160411", "termination_date": "20161107", "report_date": "20160420", "code_info": "Lot #: 6111080, Exp. 01/2017", "more_code_info": ""}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0557-2025", "product_description": "Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol,  Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "139 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0623-2023", "product_description": "Piperacillin and Tazobactam for Injection, USP, 2.25 grams per vial, Rx only, Mfd for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-002-31", "product_quantity": "110,660 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA211847"], "brand_name": ["TOBRAMYCIN OPHTHALMIC SOLUTION"], "generic_name": ["TOBRAMYCIN OPHTHALMIC SOLUTION"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-518"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TOBRAMYCIN"], "rxcui": ["313415"], "spl_id": ["5d11cea7-cb06-4ab9-930d-190549b2f4ca"], "spl_set_id": ["3c23234a-452b-40d0-922f-37e49147d537"], "package_ndc": ["62332-518-05"], "is_original_packager": [true], "nui": ["N0000175477", "M0000946"], "pharm_class_epc": ["Aminoglycoside Antibacterial [EPC]"], "pharm_class_cs": ["Aminoglycosides [CS]"], "unii": ["VZ8RRZ51VK"]}, "product_type": "Drugs", "event_id": "92811", "recalling_firm": "ALEMBIC PHARMACEUTICALS, INC.", "address_1": "550 Hills Dr Ste 104b", "address_2": "", "postal_code": "07921-1537", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1086-2023", "product_description": "Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05", "product_quantity": "82,400 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230727", "center_classification_date": "20230817", "report_date": "20230823", "code_info": "Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076667"], "brand_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "generic_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "manufacturer_name": ["The Kroger Co."], "product_ndc": ["30142-611"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE"], "rxcui": ["997406"], "spl_id": ["29c914f7-dfd8-2f34-2cab-9a239e6c58a9"], "spl_set_id": ["8cf0b878-ec13-fd44-d56f-f44af7c249ed"], "package_ndc": ["30142-611-14"], "is_original_packager": [true], "unii": ["2S068B75ZU", "6V9V2RYJ8N"]}, "product_type": "Drugs", "event_id": "89364", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0381-2022", "product_description": "Kroger, Allergy Relief-D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine HCl 120mg/Nasal Decongestant, Extended-Release Tablets USP, 20 tablets per box, NDC 30142-611-14, Distributed by the Kroger Co., Cincinnati, Ohio, 45202, Made in India.", "product_quantity": "11,064 boxes", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20220104", "center_classification_date": "20220118", "termination_date": "20231020", "report_date": "20220126", "code_info": "Lot #s: AC2000968E, Exp. 8/31/2022; AC2103328A; AC2103330I, Exp. 1/31/2023; AC2106452B, Exp. 3/31/2023."}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1690-2019", "product_description": "ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0157-20", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68557", "recalling_firm": "John W Hollis Inc", "address_1": "110 20th Ave N", "address_2": "N/A", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1392-2014", "product_description": "Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate 200 mg, also contains:  Cotton Seed Oil, Benzyl Benzoate, Benzyl Alcohol, Rx Only, 10 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234", "product_quantity": "50 mL", "reason_for_recall": "Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.", "recall_initiation_date": "20140512", "center_classification_date": "20140618", "termination_date": "20140702", "report_date": "20140625", "code_info": "lot# 1157, Use by 09/16/14; lot# 2357, use by 06/01/14", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90270", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "N/A", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0976-2022", "product_description": "AMBI Skincare Fade Cream Normal Skin, Net Wt. 2 OZ. (56g)", "product_quantity": "N/A", "reason_for_recall": "cGMP deviations: product stored outside of labeled temperature requirements.", "recall_initiation_date": "20220517", "center_classification_date": "20220531", "report_date": "20220608", "code_info": "SKUs 2024222"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0384-2017", "product_description": "QUAD2 (PAP/PHEN/ALPROS/ATRO) 9 mg/1 mg/10 mg/0.1 mg/mL Injectable a) 2 mL and b) 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 191 vials and b) 794 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 04222016@8, 06142016@42, 08152016@17    b) Known lot code: 03312016@8, 05182016@15, 08092016@18"}, {"status": "Terminated", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84610", "recalling_firm": "Appco Pharma LLC", "address_1": "262 Old New Brunswick Rd Unit N", "address_2": "N/A", "postal_code": "08854-3756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed to 6 major distributors/wholesalers some with multiple locations who may have further distribute the product.", "recall_number": "D-0649-2020", "product_description": "Ranitidine Capsules 150 mg, (a) 60 count bottles (NDC 62559-690-60) , (b) 500 count bottles (NDC 62559-690-05), Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623.", "product_quantity": "624 bottes", "reason_for_recall": "CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API", "recall_initiation_date": "20200107", "center_classification_date": "20200107", "termination_date": "20200424", "report_date": "20200115", "code_info": "Batch #   1905225VN, exp. date Apr-2021  1905226VD, exp. date Apr-2021  1906295UN, exp. date May-2021  1906296UN, exp. date May-2021  1906297UN, exp. date May-2021  1906298UD, exp. date May-2021"}, {"status": "Terminated", "city": "Salt Lake City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76676", "recalling_firm": "Isomeric Pharmacy Solution, LLC", "address_1": "2401 S Foothill Dr", "address_2": "N/A", "postal_code": "84109-1479", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0518-2017", "product_description": "Triamcinolone 40 mg/mL 2 mL Single-Dose Vial for Injection, Preservative Free, Rx only, Compounded by Isomeric  Pharmacy Solutions, Salt Lake City, UT 84109, NDC 70285-1920-1", "product_quantity": "6,999 single-use vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20170308", "center_classification_date": "20170313", "termination_date": "20170525", "report_date": "20170322", "code_info": "Lot #08016; Exp. 03/14/17  Lot #08018; Exp. 03/15/17  Lot #08023; Exp. 03/22/17  Lot #08026; Exp. 03/19/17  Lot #08033; Exp. 03/28/17  Lot #09004; Exp. 04/03/17  Lot #11014; Exp. 06/10/17  Lot #11031; Exp. 06/20/17"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0492-2018", "product_description": "Fluconazole USP for prescription compounding, packaged in a) 25g (NDC 58597-8268-4); b) 100g (NDC 58597-8268-6); c)1000g (NDC 58597-8268-8) RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "106200 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 051115-1, Exp. 4/30/2020; 081017-1, exp 11/30/2021; 122216-1,122216-2, Exp. 12/31/2020; b) 041017-1, Exp. 11/30/2021; 051115-1, Exp. 4/30/2020; 081017-1, exp 11/30/2021; c) 041017-1, 041017-2, Exp. 11/30/2021; 122216-1, 122216-2, exp. 12/31/2020"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0445-2021", "product_description": "MURO-128 2% 15ML OPTH; NDC/UPC 324208276150; OTC; DROPS", "product_quantity": "64 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66099", "recalling_firm": "JCB Labs LLC", "address_1": "7335 W 33rd St N", "address_2": "N/A", "postal_code": "67205-9368", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Guam", "recall_number": "D-1046-2013", "product_description": "Sodium Citrate 4% Solution for Injection, 30 mL Multi Dose Vial, Sterile Solution for Office Use Only, JCB Laboratories, Wichita, KS.", "product_quantity": "677 vials", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.", "recall_initiation_date": "20130823", "center_classification_date": "20130913", "termination_date": "20140818", "report_date": "20130925", "code_info": "Lot # 130710@4, Exp. 01/06/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206977"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0105", "71858-0110", "71858-0112", "71858-0113", "71858-0115", "71858-0117", "71858-0120", "71858-0125", "71858-0130", "71858-0135", "71858-0140", "71858-0145", "71858-0150", "71858-0155", "71858-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["2056462", "2056466", "2056468", "2056470", "2056472", "2056474", "2056476", "2056478", "2056480", "2056482", "2056484", "2056486", "2056488", "2056490", "2056492", "2056494", "2056496", "2056498", "2056500", "2056502", "2056504", "2056506", "2056508", "2056510", "2566608", "2566610", "2566613", "2566615", "2566617", "2566619"], "spl_id": ["2c23d44e-1a15-f636-e063-6294a90a0ed4"], "spl_set_id": ["5d378add-f13d-40f2-99dc-0f2340ab44b7"], "package_ndc": ["71858-0105-6", "71858-0105-4", "71858-0105-5", "71858-0105-1", "71858-0105-2", "71858-0110-6", "71858-0110-4", "71858-0110-5", "71858-0110-1", "71858-0110-2", "71858-0112-6", "71858-0112-4", "71858-0112-5", "71858-0112-1", "71858-0112-2", "71858-0113-6", "71858-0113-4", "71858-0113-5", "71858-0113-1", "71858-0113-2", "71858-0115-6", "71858-0115-4", "71858-0115-5", "71858-0115-1", "71858-0115-2", "71858-0117-6", "71858-0117-4", "71858-0117-5", "71858-0117-1", "71858-0117-2", "71858-0120-6", "71858-0120-4", "71858-0120-5", "71858-0120-1", "71858-0120-2", "71858-0125-6", "71858-0125-4", "71858-0125-5", "71858-0125-1", "71858-0125-2", "71858-0130-6", "71858-0130-4", "71858-0130-5", "71858-0130-1", "71858-0130-2", "71858-0135-6", "71858-0135-4", "71858-0135-5", "71858-0135-1", "71858-0135-2", "71858-0140-6", "71858-0140-4", "71858-0140-5", "71858-0140-1", "71858-0140-2", "71858-0145-6", "71858-0145-4", "71858-0145-5", "71858-0145-1", "71858-0145-2", "71858-0150-6", "71858-0150-4", "71858-0150-5", "71858-0150-1", "71858-0150-2", "71858-0155-6", "71858-0155-4", "71858-0155-5", "71858-0155-1", "71858-0155-2", "71858-0160-6", "71858-0160-4", "71858-0160-5", "71858-0160-1", "71858-0160-2"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91556", "recalling_firm": "IBSA PHARMA INC", "address_1": "8 Campus Dr Ste 201", "address_2": "N/A", "postal_code": "07054-4409", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0335-2023", "product_description": "TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0110-5", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20230130", "center_classification_date": "20230404", "termination_date": "20231031", "report_date": "20230301", "code_info": "Lot #: 220856, Exp. 2/2024."}, {"status": "Terminated", "city": "Spokane", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83253", "recalling_firm": "First Pharma Associates LLC dba Riverpoint Pharmacy", "address_1": "1802 N Monroe St", "address_2": "", "postal_code": "99205-4528", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "ID, WA only", "recall_number": "D-1474-2019", "product_description": "Hydroxyprogesterone Caproate 250 mg/mL Sesame Oil Injection, 5 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252", "product_quantity": "50 mL", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20190626", "center_classification_date": "20190711", "termination_date": "20230606", "report_date": "20190717", "code_info": "Lot #: 05152019@17, Exp. 08/13/2019", "more_code_info": ""}, {"country": "United States", "city": "Melbourne", "address_1": "1515 Elizabeth St Ste J", "reason_for_recall": "Lack of assurance of sterility.", "address_2": "", "product_quantity": "", "code_info": "All lots remaining within expiry.", "center_classification_date": "20190910", "distribution_pattern": "Continental U.S. and Puerto Rico", "state": "FL", "product_description": "Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901", "report_date": "20190918", "classification": "Class II", "openfda": {}, "recalling_firm": "Pacifico National, Inc. dba AmEx Pharmacy", "recall_number": "D-1850-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "83702", "termination_date": "20201008", "more_code_info": "", "recall_initiation_date": "20190830", "postal_code": "32901-3000", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78991", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "N/A", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed U.S.A. nationwide.", "recall_number": "D-0332-2018", "product_description": "Sterilized water for injections BP, 50 x 5 mL plastic ampules, Manufactured in India", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.", "recall_initiation_date": "20180119", "center_classification_date": "20180205", "termination_date": "20180913", "report_date": "20180214", "code_info": "all lots"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091596"], "brand_name": ["TRANEXAMIC ACID"], "generic_name": ["TRANEXAMIC ACID"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-563"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TRANEXAMIC ACID"], "rxcui": ["238720"], "spl_id": ["ddb5d068-9d9e-45da-92d7-516dd792af1b"], "spl_set_id": ["c6c3da51-fc45-4d5c-b983-1576830c95dd"], "package_ndc": ["63323-563-01", "63323-563-10", "14789-500-10"], "is_original_packager": [true], "upc": ["0363323563011"], "nui": ["N0000175634", "N0000175632"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "unii": ["6T84R30KC1"]}, "product_type": "Drugs", "event_id": "66678", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide", "recall_number": "D-1034-2014", "product_description": "Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only.  Mfd by: Fresenius Kabi USA, LLC   Packaged under two labels: 1) Mfd for: APP Pharmaceuticals, LLC; Schaumburg, IL 60173, NDC 63323-563-10, and 2) Mfd in USA; for Nexus Pharmaceuticals Inc; Vernon Hills, IL 60061.  NDC 14789-500-10.", "product_quantity": "121,456 vials", "reason_for_recall": "Presence of Particulate Matter: Particulate matter consistent with delamination of the glass vial container.", "recall_initiation_date": "20131031", "center_classification_date": "20140123", "termination_date": "20160107", "report_date": "20140129", "code_info": "National Drug Code (NDC): 63323-563-10;    Lot Numbers and (Expiration Dates): 011713 (01/2015); 012213 (01/2015), 032913 (03/2015), 041613 (04/2015); 042513 (04/2015), 042613 (04/2015), 052213 (05/2015), 092612 (09/2014), 111512 (11/2014)    NDC: 14789-500-10;   122911 (12/2013), 123011 (12/2013)", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.", "address_2": "", "product_quantity": "100 syringes", "code_info": "Lot #: 6/12/18 0432 149-21072S, BUD 9/10/18", "center_classification_date": "20180625", "distribution_pattern": "Distributed to one medical center in Fort Worth, TX.", "state": "TX", "product_description": "fentanyl Citrate USP 5 mcg in 0.9% Sodium Chloride USP 0.5 mL, 10 mcg per mL prefilled syringe, Rx only, Advanced Pharma an FDA Regulated 503B Outsourcing Facility 9265 Kirby Dr., Houston, TX  77054, NDC 15082-210-72.", "report_date": "20180704", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0889-2018", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "80354", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20180620", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0445-2019", "product_description": "Glutathione Injection, 200 mg/mL, 10 mL, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "288 10 ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 09172018@7 BUD: 12/16/2018; 10292018@2 BUD: 1/27/2019"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-034-2014", "product_description": "AMIC-12 with lido 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "7 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0905-2019", "product_description": "Dr. King's Aquaflora Probiotic Restoration Lower GI Homeopathic, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955232025, NDC 57955-3320-2", "product_quantity": "3840 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 020618D Exp. 02/20; 030916P Exp. 03/19; 041215I Exp. 04/18; 072216L Exp. 07/19"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #:  0370657    0391175    0397241      0397241", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEXPANTHENOL 250MG/ML INJECTABLE 100 ML, 120 ML, 360 ML, 450 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1499-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94691", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0563-2024", "product_description": "Progesterone 200 mg, Compounded, 90-count bottle, Rx, Dissolve One Sublingual Tablet After Dinner Nightly, AnazaoHealth, 5710 Hoover Blvd, Tampa, Fl 33643, (800)-995-4363. Beyond Use Date: 09/08/2024.", "product_quantity": "9896 tablets", "reason_for_recall": "Presence of Foreign Substance; Broken metal piece found embedded in tablet.", "recall_initiation_date": "20240424", "center_classification_date": "20240622", "report_date": "20240703", "code_info": "Product lot:  240312JL-629220; Exp. 09/08/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1171-2019", "product_description": "Prostaglandin Quad-Mix 20:30:1:0.15 Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "40 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201967"], "brand_name": ["RIZATRIPTAN BENZOATE"], "generic_name": ["RIZATRIPTAN BENZOATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-465", "68462-466"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIZATRIPTAN BENZOATE"], "rxcui": ["312840", "314209"], "spl_id": ["c7909d7b-34a6-42b0-ad12-eb25f3ce886e"], "spl_set_id": ["99c66300-bd75-4b31-9fab-88c6e4b12688"], "package_ndc": ["68462-465-72", "68462-465-99", "68462-466-72", "68462-466-99"], "is_original_packager": [true], "upc": ["0368462465998", "0368462466995"], "unii": ["WR978S7QHH"]}, "product_type": "Drugs", "event_id": "94606", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0533-2024", "product_description": "Rizatriptan Benzoate Tablets USP, 10 mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Product of India, NDC 68462-466-99", "product_quantity": "11,976 cartons", "reason_for_recall": "CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.", "recall_initiation_date": "20240510", "center_classification_date": "20240604", "report_date": "20240612", "code_info": "Lot#: 19224217; Exp. 9/2024 Lot#: 19233789; Exp. 9/2025 Lot#: 19224444; Exp. 9/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Attleboro", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68136", "recalling_firm": "Mangiacotti", "address_1": "117 Pleasant Street", "address_2": "N/A", "postal_code": "02703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1304-2014", "product_description": "Mangiacotti\t - Lavender Hand Sanitizer Spray, alcohol free, 0.5 fl Oz. 15 mL spray bottle, UPC 870678005313, Active Ingredient Benzalkonium Chloride 0.1%, Dist by: Mangiacotti, Attleboro, MA 02703 .", "product_quantity": "N/A", "reason_for_recall": "Microbial Contamination of Non-Sterile Products:  Elevated counts of bacteria was found, Serratia liquefaciens.", "recall_initiation_date": "20131227", "center_classification_date": "20140506", "termination_date": "20160429", "report_date": "20140514", "code_info": "Lot Code:  13348"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-878-2015", "product_description": "Retinoic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-570-2015", "product_description": "Celecoxib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2900 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69572", "recalling_firm": "Prometheus Laboratories Inc.", "address_1": "9410 Carroll Park Dr", "address_2": "N/A", "postal_code": "92121-5201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0249-2015", "product_description": "Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b)  250-count bottle (NDC 49884-922-04), RX only, Manufactured by Stason Pharmaceuticals, Inc., 11 Morgan, Irvine, CA 92618 for Prometheus Laboratories, Inc., 9410 Carroll Park Drive, San Diego, CA 92121", "product_quantity": "16,296 bottles (60-count),  5,166 bottles (250-count)", "reason_for_recall": "Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.", "recall_initiation_date": "20141022", "center_classification_date": "20141114", "termination_date": "20160218", "report_date": "20141126", "code_info": "Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b)  250-count bottle (NDC 49884-922-04), RX only, Manufactured by Stason Pharmaceuticals, Inc., 11 Morgan, Irvine, CA 92618 for Prometheus Laboratories, Inc., 9410 Carroll Park Drive, San Diego, CA 92121    Lot #:  a) 140B11, Exp Feb 2016; 14B012, Exp Feb 2016;   14B013, Exp Feb 2016    Lot #: b) 13F046, Exp Jun 2015; 13K073, Exp Oct 2015; 13L075, Exp Oct 2015; 14B010, Exp Feb 2016."}, {"country": "United States", "city": "Frisco", "address_1": "5134 Navajo Dr", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil and tadalafil and undeclared milk. The presence of sildenafil and tadalafil makes AMPT Natural Herbal Coffee an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. Additionally, this product has been found to contain undeclared milk, milk is recognized as one of the foods reported to have caused deaths due to anaphylactic shock in persons with underlying hypersensitivities.", "address_2": "", "product_quantity": "1380 packets", "code_info": "All lots", "center_classification_date": "20171221", "distribution_pattern": "Nationwide in the USA", "state": "TX", "product_description": "NATURAL HERBAL COFFEE AMPT, sold in 25g packages (UPC 6942630905), 10-count packages per box (UPC 6942630912); Manufactured For: The Ampt Life, LLC.", "report_date": "20171227", "classification": "Class I", "openfda": {}, "recalling_firm": "The Ampt Life, LLC", "recall_number": "D-0126-2018", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "77859", "termination_date": "20180906", "more_code_info": "", "recall_initiation_date": "20170801", "postal_code": "75034-1275", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0397-2024", "product_description": "fentaNYL 200 mcg/100 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 100 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0231-32, Bar Code 70004023132", "product_quantity": "242 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048855, Exp 12/6/23", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0275-2016", "product_description": "Phenylephrine (1 mg/mL), 5 mL Multi-Dose Vial, For SC, IM, IV or penile injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3289-05", "product_quantity": "11 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20150904@11 BUD: 10/6/2015"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "5 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 22.5/0.83 mg/8.3 mcg/mL; 5 mL and 10 mL unit sizes, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0698-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "10 ml", "code_info": "All lots distributed between November 2014 and May 2015;  04302015@29, 10/27/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix ST2 (30 mg/3 mg/100 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1793-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Hanover", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA022291"], "brand_name": ["PROMACTA"], "generic_name": ["ELTROMBOPAG OLAMINE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0684", "0078-0685", "0078-0686", "0078-0687", "0078-0972", "0078-0697"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ELTROMBOPAG OLAMINE"], "rxcui": ["825421", "825425", "825427", "825429", "884617", "884619", "1245001", "1245003", "1859498", "1859501", "2058980", "2058981"], "spl_id": ["697f8c94-cdbe-4e85-9b82-a9d9691a0736"], "spl_set_id": ["7714a0ed-34bb-46e6-a0a5-b363908b22c2"], "package_ndc": ["0078-0684-15", "0078-0685-15", "0078-0686-15", "0078-0686-55", "0078-0687-15", "0078-0972-19", "0078-0972-23", "0078-0972-61", "0078-0697-19", "0078-0697-23", "0078-0697-61"], "is_original_packager": [true], "unii": ["4U07F515LG"]}, "product_type": "Drugs", "event_id": "82820", "recalling_firm": "Novartis Pharmaceuticals Corp.", "address_1": "1 Health Plz", "address_2": "N/A", "postal_code": "07936-1016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide with in the United States", "recall_number": "D-1309-2019", "product_description": "Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only  Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981   Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936  Product of Ireland, NDC 0078-0972-61.", "product_quantity": "792 cartons", "reason_for_recall": "Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.", "recall_initiation_date": "20190511", "center_classification_date": "20190529", "termination_date": "20231128", "report_date": "20190529", "code_info": "Lot #: 8H57901589, Exp. 09/2020; 9H57900189 and 9H57900289, Exp. 12/2020."}, {"country": "United States", "city": "Smyrna", "address_1": "1 Swan Dr", "reason_for_recall": "Presence of foreign substance: glass particle", "address_2": "", "product_quantity": "52,212 bottles", "code_info": "Lot: 0313246", "center_classification_date": "20170621", "distribution_pattern": "Nationwide U.S.A.", "state": "TN", "product_description": "Magnesium Citrate Saline Laxative Cherry Flavored, packaged in a) 10 fl. oz. (296 mL) bottle UPC: 072785104556 (Rexall's label), b) 10 fl. oz. (296 mL) bottle UPC: 041163254138 (Equaline's label), OTC, Distributed by a) Dolgencorp, LL, Goodlettsville, TN 37072 b)Supervalu, Inc. Eden Prairie, MN 55344", "report_date": "20170628", "classification": "Class II", "openfda": {}, "recalling_firm": "Vi-Jon, Inc.", "recall_number": "D-0922-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77517", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20170612", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sunrise", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64846", "recalling_firm": "Actavis South Atlantic LLC", "address_1": "13800 Nw 2nd St Ste 190", "address_2": "N/A", "postal_code": "33325-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-248-2013", "product_description": "buPROPion Hydrochloride Extended-Release Tablets (XL) 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic LLC, Sunrise, FL  33325; Packaged by: American Health Packaging, Columbus, OH  43217; NDC 67767-142-30.", "product_quantity": "555,672 bottles", "reason_for_recall": "Failed USP Dissolution Test Requirements: Out-of-specification dissolution results at the 8 hour stability testing point.", "recall_initiation_date": "20130322", "center_classification_date": "20130412", "termination_date": "20140509", "report_date": "20130424", "code_info": "Lot #: CC1D11A, CC1D12A, CC1D17A, CC1D18A, CD1D05A, CD1D07A, CD1D08A, CD1D14A, CD1D15A, CD1D16A, CE1D08A, Exp 03/13;     CE1D03A, CE1D04A, CE1D07A, CE1D06A, CE1D05A, CE1D13A, CE1D14A,  CE1D15A, Exp 04/13;     CF1D01A, CE1D24A, CF1D02A, Exp 05/13;     CH1D08A, CH1D09A, Exp 07/13;     CJ1D01A, CH1D11A, CH1D10A, CJ1D09A, CJ1D02A, CJ1D10A Exp 08/13;     CL1D05A, CL1D06A, CK1D05B, CK1D06A, Exp 10/13;     CL1D08A, CM1D01A, CM1D02A, Exp 11/13"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206245"], "brand_name": ["HYDROCODONE BITARTRATE AND ACETAMINOPHEN"], "generic_name": ["HYDROCODONE BITARTRATE AND ACETAMINOPHEN"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-356", "43386-358", "43386-357"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "HYDROCODONE BITARTRATE"], "rxcui": ["856999", "857002", "857005"], "spl_id": ["2cb73d19-0ef9-4d59-a2de-b7b2b3a369a1"], "spl_set_id": ["26a2178e-e0e5-4d61-81fd-e30a3142f1f2"], "package_ndc": ["43386-358-05", "43386-358-01", "43386-358-10", "43386-358-03", "43386-357-01", "43386-357-05", "43386-357-10", "43386-357-03", "43386-356-01", "43386-356-05", "43386-356-10", "43386-356-03", "3433863561"], "is_original_packager": [true], "upc": ["0343386357031", "0343386358014", "0343386356010", "343386356102"], "unii": ["362O9ITL9D", "NO70W886KK"]}, "product_type": "Drugs", "event_id": "80187", "recalling_firm": "LUPIN SOMERSET", "address_1": "400 Campus Dr", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH", "recall_number": "D-0836-2018", "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 5 mg/325 mg, 1000-count bottle Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset NJ 08873  Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 212020  NDC 43386-356-10  UPC 343386356102", "product_quantity": "1,672 (1000-count) bottles", "reason_for_recall": "Labeling: Missing Label", "recall_initiation_date": "20180524", "center_classification_date": "20180531", "termination_date": "20210126", "report_date": "20180606", "code_info": "Lot # S800257; Exp. 01/20"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "9 units", "code_info": "Rx #'s:C0388707  C0393621  C0397891  C0397894  C0397896  C0397905  C0404812  C0405366  C0407575", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEPO-TESTOSTERONE, MDV, 10ML** 200MG/ML INJECTABLE 10 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1496-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0292-2016", "product_description": "Vitamin D3 in Olive Oil (50,000 IU/mL) 30 mL vial, For IM Use only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3277-06", "product_quantity": "55 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20151703@26 BUD: 9/13/2015, 20151703@26 BUD: 9/13/2015"}, {"country": "United States", "city": "Cranbury", "address_1": "270 Prospect Plains Rd", "reason_for_recall": "Failed Impurities/Degradation Specifications", "address_2": "", "product_quantity": "3,889 HDPE bottles", "code_info": "Lot # AVF0258/A, AVF0258/B, AVF0258/C, AVF0259/A, AVF0259/C; Exp. 02/17", "center_classification_date": "20160916", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Carvediol Tablets, USP, 25 mg, 100-count bottle (NDC 57664-247-88), 500-count bottle (NDC 57664-247-13), 1000-count bottle (NDC 57664-247-18), Rx Only Manufactured by: ALKALOIDA Chemical Company Zrt 440 Tisavasvari Kabay Janos u.  29 Hungary,  Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512", "report_date": "20160928", "classification": "Class III", "openfda": {}, "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "recall_number": "D-1507-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74694", "termination_date": "20180326", "more_code_info": "", "recall_initiation_date": "20160627", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0167-2022", "product_description": "TEST CYPIONATE 200MG/DUTASTERIDE 2MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1007222021:38 BUD: 01/18/2022", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: TACROLIMUS, Capsule, 0.5 mg may have potentially been mislabeled as one of the following drugs:  CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: W003168, EXP: 6/13/2014;  ISOSORBIDE MONONITRATE ER, Tablet, 30 mg, NDC 62175012837, Pedigree: W003350, EXP: 6/18/2014.", "address_2": "", "product_quantity": "200 Capsules", "code_info": "TACROLIMUS, Capsule, 0.5 mg has the following codes:   Pedigree: W003169, EXP: 6/13/2014;  Pedigree: W003351, EXP: 6/18/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TACROLIMUS, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781210201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1006-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0698-2023", "product_description": "Neonatal PN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with low calcium and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100 Allentown, PA  18106, NDC 71285-0429-1.", "product_quantity": "328 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-894695, Exp 04/30/2023; 37-895693, Exp 05/05/2023; 37-900065, Exp 05/21/2023; 37-900622, Exp 05/25/2023"}, {"status": "Terminated", "city": "Littleton", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83397", "recalling_firm": "Wise Pharmacy", "address_1": "6179 S Balsam Way Ste 150", "address_2": "N/A", "postal_code": "80123-3095", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO, TX, WY", "recall_number": "D-1570-2019", "product_description": "Gentamicin (GU) Irrigation 240 mg/500 mL Solution, 250 mL Container, Shake well and Refrigerate, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.", "product_quantity": "1 container", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20190722", "center_classification_date": "20190731", "termination_date": "20200203", "report_date": "20190807", "code_info": "Lot #: 7179N, Exp 7/16/2019"}, {"status": "Terminated", "city": "Seminole", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78939", "recalling_firm": "International Laboratories, Inc.", "address_1": "6950 Bryan Dairy Rd Ste A", "address_2": "N/A", "postal_code": "33777-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0234-2018", "product_description": "Pravastatin Sodium Tablets, USP, 20 mg, 30-count bottles, packaged in 12 x 30 tablets for individual patient dispensing per pharmacy dispenser carton, Rx only, Packaged for: International Laboratories, LLC. St. Petersburg, FL 33710, NDC 54458-926-16.", "product_quantity": "13,403 cartons", "reason_for_recall": "Presence of Foreign Tablets/Capsules: bottles could contain both pravastatin sodium 10 mg and 20 mg tablets in the same bottle.", "recall_initiation_date": "20180112", "center_classification_date": "20180124", "termination_date": "20190501", "report_date": "20180131", "code_info": "Lot: 117103A, Exp. 03/19"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0483-2025", "product_description": "Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "826 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot #BH11235 exp 5/5/2025 ; BH11235 , exp 5/5/2025 ; BH11235 , exp 5/5/2025 ; BH11235 , exp 5/5/2025 ; BH11235 , exp 5/5/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; BH272962 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; BH272962 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; BH00048 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRO30625-2 , exp 9/2/2025 ; PRO30625-2 , exp 9/2/2025 ; PRO30625-2 , exp 9/2/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA019258"], "brand_name": ["SCRUB-STAT"], "generic_name": ["CHLORHEXIDINE GLUCONATE"], "manufacturer_name": ["Ecolab Inc."], "product_ndc": ["47593-468"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE"], "rxcui": ["211365", "1655179"], "spl_id": ["e5069361-cd7b-485e-8eba-daa3b40e7c47"], "spl_set_id": ["c126e473-e9ae-4749-a5e9-07191ec8c1fb"], "package_ndc": ["47593-468-41", "47593-468-59", "47593-468-44", "47593-468-21", "47593-468-36", "47593-265-36"], "is_original_packager": [true], "unii": ["MOR84MUD8E"]}, "product_type": "Drugs", "event_id": "73264", "recalling_firm": "Ecolab Inc", "address_1": "370 Wabasha St N", "address_2": "N/A", "postal_code": "55102-1323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico and Canada", "recall_number": "D-0766-2016", "product_description": "Scrub-Stat 4 (chlorhexidine gluconate) Foam  Forming Solution, 4%, packaged in a) 800 mL Plastic (HDPE) Bottles (NDC 47593-265-36), b) 1250 mL Plastic (HDPE) Bottles (NDC 47593-468-59), OTC, Ecolab, St Paul, MN 55102", "product_quantity": "706 bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20160212", "center_classification_date": "20160308", "termination_date": "20170324", "report_date": "20160316", "code_info": "Lot #: a) L041051, Exp 04 \u0013/17; L060151, L061951, Exp 06 \u0013/17; b) L060151, L061951, Exp 06 \u0013/17"}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88847", "recalling_firm": "Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals", "address_1": "1919 N Victory Pl", "address_2": "", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0256-2022", "product_description": "Butalbital, APAP, Caf 50/325/40 Tablets, packaged in a) 12-count bottles, NDC: 63629-8392-09, barcode 083929152151; b) 60-count bottles, NDC: 63629-8392-03, barcode 083923152614; c) 90-count bottles, NDC:63629-8392-04, barcode 083924152614, Lannett Company Inc; Rx only, Packaged by Bryant Ranch Prepack, Burbank, CA 91504.", "product_quantity": "119 Bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: the controlled substance classification \"CIII\" is missing on the label", "recall_initiation_date": "20210928", "center_classification_date": "20211123", "report_date": "20211201", "code_info": "a) Lots: 152838, 152156, 152151, 151708, 151693, 151375, 151131, 151114, Exp: 7/31/2022, b) Lots: 152245, 151822, 151708, 151160, 151131, Exp: 7/31/2022, c) Lot #: 152614, Exp: 7/31/2022.", "more_code_info": ""}, {"country": "United States", "city": "Olive Branch", "address_1": "1 & 2", "reason_for_recall": "Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.", "address_2": "154 Downing Street", "product_quantity": "Unknown", "code_info": "Lot #: 15517VP01, 15517VP02, 15517VP03, Exp 8/31/2019; 15518001, Exp 12/31/2019; 15518002, Exp 3/31/2020.", "center_classification_date": "20180907", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "state": "MS", "product_description": "Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-155-04.", "report_date": "20180829", "classification": "Class I", "openfda": {}, "recalling_firm": "Westminster Pharmaceuticals LLC", "recall_number": "D-1180-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80719", "termination_date": "20200603", "more_code_info": "", "recall_initiation_date": "20180803", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89395", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0376-2022", "product_description": "Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only,  Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04", "product_quantity": "18,456 bottles", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20220107", "center_classification_date": "20220118", "termination_date": "20241213", "report_date": "20220126", "code_info": "Lots #: 678900, 682000, 682400, Exp. 5/31/2022; 680600, 680800, 681000 Exp. 5/30/2022; 683200, 685200 Exp. 6/30/2022; 728900, 733100 Exp. Date 12/31/2022; 738600 Exp. 1/31/2023; 740600, 741600 Exp. 2/28/2023; 749800, 750900, 752400 Exp. 3/31/2023; 775700 Exp. 6/30/2023"}, {"status": "Terminated", "city": "Bronx", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73018", "recalling_firm": "R Thomas Marketing, LLC", "address_1": "3704 White Plains Rd", "address_2": "N/A", "postal_code": "10467-5710", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via Internet sales", "recall_number": "D-0889-2016", "product_description": "African Black Ant, packaged in 8 small boxes / 6 capsules per box / 48 capsules total, Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA", "recall_initiation_date": "20160109", "center_classification_date": "20160526", "termination_date": "20190621", "report_date": "20160601", "code_info": "all lots"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; tiZANidine HCl Tablet, 2 mg may be potentially mislabeled as    RIBAVIRIN, Capsule, 200 mg, NDC 68382026007, Pedigree: AD21790_37, EXP: 4/30/2014;  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD46257_59, EXP: 5/15/2014;  NIACIN, Tablet, 100 mg, NDC 00904227160, Pedigree: W002661, EXP: 6/5/2014;  PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC 00008060601, Pedigree", "address_2": "", "product_quantity": "600 Tablets", "code_info": "tiZANidine HCl, Tablet, 2 mg has the following codes    Pedigree: AD21790_40, EXP: 5/1/2014;  Pedigree: AD46265_16, EXP: 5/15/2014;  Pedigree: W002663, EXP: 6/5/2014;  Pedigree: AD73525_31, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "tiZANidine HCl Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 55111017915", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-621-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077614"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-092", "68382-093", "68382-094", "68382-095"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["2e368267-8da4-4606-9348-0246a064016c"], "spl_set_id": ["dc6a2d33-aa04-4a04-9cde-901b744d24ca"], "package_ndc": ["68382-092-17", "68382-092-01", "68382-092-05", "68382-093-17", "68382-093-05", "68382-093-01", "68382-094-17", "68382-094-01", "68382-094-05", "68382-095-17", "68382-095-01", "68382-095-05"], "is_original_packager": [true], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "88482", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0753-2021", "product_description": "Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05", "product_quantity": "2880 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle", "recall_initiation_date": "20210813", "center_classification_date": "20210819", "termination_date": "20230403", "report_date": "20210825", "code_info": "Z006279, exp 12/31/2022"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "11 units", "code_info": "Rx #'s:   0370173      0370173    0370173    0370173    0371532      0371532    0371532      0371532", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE/EPINEPHRINE/BUPIVACAINE, PF 1%/0.00025%/0.375% OPHTHALMIC\t30 ML  \t  \t48 ML  \t60 ML  \t90 ML;  LIDOCAINE/EPINEPHRINE/BUPIVACAINE, PF 1%/0.0005%/0.25% OPHTHALMIC\t30 ML  \t  \t48 ML  \t60 ML  \t  \t90 ML  (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1561-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69494", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, and U.S. Virgin Islands.", "recall_number": "D-0278-2015", "product_description": "Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7902-09.", "product_quantity": "836,460 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.", "recall_initiation_date": "20141014", "center_classification_date": "20141125", "termination_date": "20151228", "report_date": "20141203", "code_info": "Lot # 34-017-JT; Exp. 10/15  Lot # 35-100-JT; Exp. 11/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Conshohocken", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97329", "recalling_firm": "IMMUNOCORE, LLC", "address_1": "Six Tower Bridge", "address_2": "181 Washington St Ste 540", "postal_code": "19428-2068", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "US Nationwide", "recall_number": "D-0614-2025", "product_description": "KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kingdom, For: Immunocore Commercial LLC, 181 Washington St, Conshohocken, PA, 19428, Product of Denmark   NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026   NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026", "product_quantity": "7,572 vials", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250610", "center_classification_date": "20250903", "report_date": "20250910", "code_info": "NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026   NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026"}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0747-2016", "product_description": "Morphine Sulfate 10 mg/ml, vol. 20 ml syringe, Rx only,   Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date.", "address_2": "", "product_quantity": "", "code_info": "lot# D001 EXP: 01/02/2018 CPD: 01/02/2019", "center_classification_date": "20180629", "distribution_pattern": "Nationwide in the USA", "state": "OK", "product_description": "TESTOSTERONE 200 mg PELLET, 1-count 3ml amber vial. RX only. Compounded by: Qualgen 14844 Bristol Park Blvd, Edmond OK 73013. NDC 69761-120-01", "report_date": "20180711", "classification": "Class III", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0893-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80203", "termination_date": "20201125", "more_code_info": "", "recall_initiation_date": "20180608", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Sartell", "address_1": "165 19th St S", "reason_for_recall": "Lack of assurance of sterility:  This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due to unsubstantiated validation of beyond use dating.", "address_2": "Suite 102", "product_quantity": "10 mL", "code_info": "LOT #: 06201604@15,  19201602@3,  06201604@8", "center_classification_date": "20160916", "distribution_pattern": "MN", "state": "MN", "product_description": "Prostaglandin 200 mcg/ 0.1 mL  --  25 mL GLASS VIAL, Rx only, THE APOTHECARY, A COMPOUNDING PHARMACY, 165 19th St S #102,  Sartell, MN 56377", "report_date": "20160928", "classification": "Class II", "openfda": {}, "recalling_firm": "W & C dba The Apothecary", "recall_number": "D-1512-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74606", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20160620", "postal_code": "56377-2567", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88861", "recalling_firm": "Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals", "address_1": "1919 N Victory Pl", "address_2": "N/A", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0092-2022", "product_description": "Methocarbamol 500mg Tablet, packaged in a) #30 count (NDC 7133517952), b) #60 count (NDC 7133517954), and c) #90 count (NDC 7133517957) bottles, Rx only, Prinston Laboratories, Packaged by Bryant Ranch Prepack Burbank, CA 91504", "product_quantity": "a) 124, b) 29, c) 73", "reason_for_recall": "Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets", "recall_initiation_date": "20211012", "center_classification_date": "20211102", "report_date": "20211110", "code_info": "Lot #: 163935, Exp: 10/31/2022"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1126-2020", "product_description": "Fungo Balm, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-  0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Verna, Salcette, Goa", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA078043"], "brand_name": ["AMLODIPINE BESYLATE"], "generic_name": ["AMLODIPINE BESYLATE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-233", "68180-750", "68180-751", "68180-752", "68180-719", "68180-720", "68180-721", "68180-455"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE"], "rxcui": ["197361", "308135", "308136"], "spl_id": ["63bc4df8-5e26-45dd-8a05-78ee94553129"], "spl_set_id": ["003dd1ec-16f8-4f96-b6a8-c4689d35892a"], "package_ndc": ["68180-750-09", "68180-751-09", "68180-751-03", "68180-751-17", "68180-752-09", "68180-752-03", "68180-719-03", "68180-719-09", "68180-720-09", "68180-720-03", "68180-721-03", "68180-721-09", "68180-233-01", "68180-233-02", "68180-455-02", "68180-455-01"], "is_original_packager": [true], "unii": ["864V2Q084H"]}, "product_type": "Drugs", "event_id": "74964", "recalling_firm": "Lupin Limited", "address_1": "15-B, Phase 1A, Verna Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US      No recalled product was distributed to any foreign consignees by Lupin.", "recall_number": "D-1492-2016", "product_description": "Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-750-09", "product_quantity": "43,536 bottles", "reason_for_recall": "CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.", "recall_initiation_date": "20160219", "center_classification_date": "20160906", "termination_date": "20170403", "report_date": "20160914", "code_info": "Lot #: G304799, Exp. 4/2016", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Gent 80 mg/Liter Nasal, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0406-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA018998"], "brand_name": ["VASOTEC"], "generic_name": ["ENALAPRIL MALEATE"], "manufacturer_name": ["Bausch Health US LLC"], "product_ndc": ["0187-0140", "0187-0141", "0187-0142", "0187-0143"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENALAPRIL MALEATE"], "rxcui": ["858804", "858806", "858810", "858812", "858813", "858815", "858817", "858819"], "spl_id": ["18a458cc-976a-4019-bd85-18f55a224f45"], "spl_set_id": ["39631f1f-5d19-43c1-b504-bf56d991ed97"], "package_ndc": ["0187-0140-30", "0187-0140-90", "0187-0141-30", "0187-0141-90", "0187-0141-10", "0187-0142-30", "0187-0142-90", "0187-0142-10", "0187-0143-30", "0187-0143-90", "0187-0143-10"], "is_original_packager": [true], "unii": ["9O25354EPJ"]}, "product_type": "Drugs", "event_id": "68572", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0019-2015", "product_description": "Vasotec (enalapril maleate) tablets, RX only, Manufactured by Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada    2.5 mg  90 ct -  NDC 0187-0140-90    5 mg 30 ct - NDC  0187-0141-30    5 mg 90 ct - NDC 0187-0141-90    10 mg 30 ct - NDC 0187-0142-30    10 mg 90 ct - NDC 0187-0142-90    10 mg  1000 ct - NDC 0187-0142-10      20 mg 30 ct - NDC 0187-0143-30    20 mg 90 ct - NDC 0187-0143-90     20 mg 1000 ct - NDC 0187-0143-10          NDC #'s 64455-140, 64455-141, 64455-142 and 64455-143, 30 ct. bottles, 90 ct. bottles and 1000 ct. bottles", "product_quantity": "205,853 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.", "recall_initiation_date": "20140521", "center_classification_date": "20141010", "termination_date": "20150804", "report_date": "20141022", "code_info": "VASOTEC 2.5MG TAB 30CT  12K015P  exp.  9/30/2014      VASOTEC 2.5MG TAB 30CT  13G048P   exp.  07/31/2015    VASOTEC 2.5MG TAB 30CT  14A065P   exp. 07/31/2015    VASOTEC 2.5MG TAB 90CT  13G020P   exp. 07/31/2015      VASOTEC 2.5MG TAB 90CT   12K020P  exp.  9/30/2014      VASOTEC 2.5MG TAB 90CT  13B016P   exp. 9/30/2014      VASOTEC 5MG TAB 30CT   13B022P   exp. 2/28/2015    VASOTEC 5MG TAB 30CT 13B023P   exp. 2/28/2015    VASOTEC 5MG TAB 30CT  13C015P   exp. 02/28/2015    VASOTEC 5MG TAB 30CT  13E002P   exp. 02/28/2015    VASOTEC 5MG TAB 30CT 14A002P   exp.    11/30/2015    VASOTEC 5MG TAB 30CT  13L066P   exp. 11/30/2015    VASOTEC 5MG TAB 90CT   13B018P   exp. 2/28/2015      VASOTEC 5MG TAB 90CT  13G015P   exp. 06/30/2015      VASOTEC 10MG TAB 90CT   12M017P   exp. 11/30/2014    VASOTEC 10MG TAB 1000CT   12L105P   exp. 11/30/2014      VASOTEC 10MG TAB 30CT   12M016P   exp. 11/30/2014      VASOTEC 10MG TAB 30CT  13G013P   exp. 06/30/2015    VASOTEC 10MG TAB 30CT  13J081P  exp. 9/30/2015    VASOTEC 10MG TAB 90CT 12M025P   exp. 11/30/2014    VASOTEC 10MG TAB 90CT  13J082P   exp. 0/2015    VASOTEC 10MG TAB 90CT  13J085P   exp. 0/2015    VASOTEC 10MG TAB 90CT  13J094P   exp. 09/30/2015    VASOTEC 10MG TAB 1000CT  13J098P   exp. 09/30/2015    VASOTEC 10MG TAB 1000CT  13G011P   exp. 06/30/2015    VASOTEC 10MG TAB 1000CT  13J097P   exp. 09/30/2015    VASOTEC 20MG TAB 30CT   12J017P   exp. 5/31/2014    VASOTEC 20MG TAB 30CT   13C016P   exp. 2/28/2015    VASOTEC 20MG TAB 30CT  13E003P   exp. 02/28/2015    VASOTEC 20MG TAB 30CT  13L068P   exp. 09/30/2015    VASOTEC 20MG TAB 90CT  13J086P   exp. 09/30/2015    VASOTEC 20MG TAB 90CT  13J087P   exp. 09/30/2015      VASOTEC 20MG TAB 90CT   12M029P   exp. 11/30/2014    VASOTEC 20MG TAB 90CT   12M030P   exp. 11/30/2014    VASOTEC 20MG TAB 1000CT   12J023P   exp. 5/31/2014    VASOTEC 20MG TAB 1000CT  12L108P   exp. 11/30/2014    VASOTEC 20MG TAB 1000CT  13C088P   exp. 02/28/2015    VASOTEC 20MG TAB 1000CT  13J099P   exp. 09/30/2015    VASOTEC 20MG TAB 1000CT  13M054P   exp. 09/30/2015    VASOTEC 20MG TAB 1000CT  13M055P   exp. 12/31/2015    VASOTEC 20MG TAB 1000CT  14B054P   exp. 12/31/2015"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0844-2019", "product_description": "Dr. King's SafeCare Rx Teeth & Gum Formula, 2 fl. oz. (59 mL), NDC 57955-0073-2 UPC 357955007326 King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA", "product_quantity": "492 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 062415E Exp. 06/18; 071116D Exp. 07/18; 121317H Exp. 12/19"}, {"status": "Ongoing", "city": "Mumbai", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA211417"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-393", "33342-394", "33342-395", "33342-396", "33342-397", "33342-398", "33342-399", "33342-400", "33342-401", "33342-402", "33342-403", "33342-404"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["3a77ca51-7d8a-4755-aabc-3801cc772a10"], "spl_set_id": ["b8c20f76-3ee6-4b29-b77f-ed4ad1baaed9"], "package_ndc": ["33342-393-10", "33342-393-11", "33342-393-44", "33342-394-10", "33342-394-11", "33342-394-44", "33342-395-10", "33342-395-11", "33342-395-44", "33342-396-10", "33342-396-11", "33342-396-44", "33342-397-10", "33342-397-11", "33342-397-44", "33342-398-10", "33342-398-11", "33342-398-44", "33342-399-10", "33342-399-11", "33342-399-44", "33342-400-10", "33342-400-11", "33342-400-44", "33342-401-10", "33342-401-11", "33342-401-44", "33342-402-10", "33342-402-11", "33342-402-44", "33342-403-10", "33342-403-11", "33342-403-44", "33342-404-10", "33342-404-11", "33342-404-44"], "is_original_packager": [true], "upc": ["0333342393104", "0333342397102", "0333342404107", "0333342393111", "0333342400109", "0333342403100", "0333342393449", "0333342394101", "0333342402103", "0333342396105", "0333342395108", "0333342398109", "0333342399106"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96979", "recalling_firm": "Macleods Pharmaceuticals Ltd", "address_1": "304 Atlanta Arcade", "address_2": "Church Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0470-2025", "product_description": "Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.", "product_quantity": "1,344- 1000 count bottles", "reason_for_recall": "Presence of a foreign substance: black hair found embedded in tablet.", "recall_initiation_date": "20250529", "center_classification_date": "20250612", "report_date": "20250618", "code_info": "Lot #: MLF2401A, Exp 01/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1450-2022", "product_description": "QP DPHNHDRME ALRGY MIN TBLT 12 CT SKU 900449  QP ALLERGY DIPHENHYDRAMINE 25 MG 48 CT SKU 916003   QP ALLERGY MULTI SYMPTOM CAPLET 24CT SKU 916918   BENADRYL D CHILD ALLERGY SINUS GRAPE 4FO SKU 901738   GOOD SENSE CHILD ALLERGY CHERRY 4 FL OZ SKU 916917   BENADRYL ALLERGY CONGESTN ULTRA TAB 24CT SKU 999834   BENADRYL ALLERGY ULTRATAB 24CT SKU 902217   BENADRYL ALLERGY LIQUIDGELS 24 CT SKU 916715 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 900449; 916003; 916918; 901738; 916917; 999834;  902217; 916715", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "21 units", "code_info": "Rx #'s:   0392865    0396841    0392865    0389079      0401264    0401264    0389079    0351538    0379811    0398960        0396622    0367514", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CALCIUM CHLORIDE DIHYDRATE, P.F. 100MG/ML (10%) INJECTABLE 200 ML, 240 ML, 500 ML; CALCIUM EDTA 150MG/ML INJECTABLE 1000 ML, 800 ML, 900 ML; CALCIUM EDTA 300MG/ML INJECTABLE 400 ML, 500 ML; CALCIUM GLUCONATE OPHTHALMIC IN ARTIFICIAL TEARS 1%  OPHTHALMIC 500 ML (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1480-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "5 ml", "code_info": "All Lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "Estradiol cypionate/Test cyprionate; 2 mg/50 mg/ml, unit size 5 mL, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0678-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "La Habra", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80890", "recalling_firm": "Auro Pharmacies, Inc.", "address_1": "520 W La Habra Blvd", "address_2": "N/A", "postal_code": "90631-5308", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in USA", "recall_number": "D-1166-2018", "product_description": "Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial,  Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631", "product_quantity": "40 vials", "reason_for_recall": "Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.", "recall_initiation_date": "20180821", "center_classification_date": "20180829", "termination_date": "20200130", "report_date": "20180905", "code_info": "Lot #: 180611/1, Exp 09-Sep-18"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0281-2016", "product_description": "Testosterone cypionate, USP (250 mg/mL), 10 mL Multi-Dose Vial, For Deep IM Injection Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72653, NDC 62295-2131-07", "product_quantity": "2,524 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20150306@41 BUD: 11/30/2015, 20150505@56 BUD: 11/1/2015, 20150605@21 BUD: 11/2/2015, 20151607@33 BUD: 1/12/2015, 20152104@9 BUD: 10/18/2015, 20152206@24 BUD: 12/19/2015, 20151404@26 BUD: 10/11/2015, 20152104@9 BUD: 10/18/2015"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82657", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1241-2019", "product_description": "Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 25 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-25", "product_quantity": "5,380 cartons (25 ampules per carton)", "reason_for_recall": "Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit:  NMT 3.0%) at 12 months stability testing.", "recall_initiation_date": "20190423", "center_classification_date": "20190424", "termination_date": "20220728", "report_date": "20190501", "code_info": "Lot #: 011198, Exp 01/22"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "12 units", "code_info": "Rx #'s:  0387947    0391167      0394583    0394583      0394579    0390379          0390379", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HEPARIN LOCK SODIUM*** (25X1ML) 100U/ML INJECTABLE 50 ML;  HEPARIN LOCK SODIUM*** (25X5ML) 100U/ML INJECTABLE 125 MLS; HEPARIN SODIUM (25X30ML)** 1000U/ML(1MU/ML) INJECTABLE 120 ML, 60 ML, 90 ML; HEPARIN SODIUM **25X1ML 1000U/ML(1MU/ML INJECTABLE 25 ML, 50 ML (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1531-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0981-2019", "product_description": "Dr. King's Natural Medicine Good Mood Enhancer Homeopathic, 2 fl oz (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955515029, NDC 57955-8150-2", "product_quantity": "4612 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 041117E Exp. 04/20; 030118H Exp. 03/20; 040616F Exp. 04/19; 071316N Exp. 07/19; 111617C Exp. 11/19"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MINOCYCLINE HCL, Capsule, 50 mg may have potentially been mislabeled as the following drug:  MINOXIDIL, Tablet, 2.5 mg, NDC 00591564201, Pedigree: AD52778_49, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "MINOCYCLINE HCL, Capsule, 50 mg has the following codes:   Pedigree:  AD52778_46, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MINOCYCLINE HCL, Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591569401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-978-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202289"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["DirectRx"], "product_ndc": ["72189-289"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979471"], "spl_id": ["2c294389-2484-bf83-e063-6394a90a70d2"], "spl_set_id": ["d1ed9593-a587-55bb-e053-2995a90a8a9a"], "package_ndc": ["72189-289-90"], "original_packager_product_ndc": ["33342-052"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "90200", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0895-2022", "product_description": "Losartan Pot/HCTZ 100/25 mg 90 Tabs NDC 72189-289-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540", "product_quantity": "11 bottles", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .", "recall_initiation_date": "20220511", "center_classification_date": "20220524", "termination_date": "20221202", "report_date": "20220601", "code_info": "Lots: 08NO2102 Exp. 1/31/25; 17NO2118 Exp. 1/31/25; 18NO2123 Exp. 1/31/25; 25OC2114 Exp. 1/31/25; 22NO2105 Exp. 1/31/25", "more_code_info": ""}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0027-2020", "product_description": "C-PAPAV/PHENTOL/PGE1 30MG/1MG/30MCG/ML, 5 mL vial, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 062419C, BUD 08/08/19"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202289"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-050", "33342-051", "33342-052"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["cf31d31e-9355-47da-9c2b-8e4b84ac8159"], "spl_set_id": ["a04b5622-2c49-4d61-92b1-5dc523af7a24"], "package_ndc": ["33342-050-07", "33342-050-10", "33342-050-44", "33342-050-12", "33342-051-07", "33342-051-10", "33342-051-44", "33342-051-12", "33342-052-07", "33342-052-10", "33342-052-44", "33342-052-12"], "is_original_packager": [true], "upc": ["0333342051448", "0333342050106", "0333342052100", "0333342051103", "0333342052445", "0333342051073", "0333342052070"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "90037", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0837-2022", "product_description": "Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/12.5 mg, a) 30-count bottles (NDC# 33342-051-07), b) 90-count bottles (NDC # 33342-051-10)  c) 1000-count bottles (NDC # 33342-051-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220415", "center_classification_date": "20220503", "termination_date": "20231013", "report_date": "20220511", "code_info": "Lot #  BLL2107B, exp. date 05/2023  BLL2101A, exp. date 01/2025  BLL2102A, exp. date 02/2025  BLL2103B, exp. date 02/2023  BLL2104A, exp. date 05/2023"}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71973", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0025-2016", "product_description": "Equaline Original Prescription Strength, loratadine orally disintegrating tablets, USP, 10 mg, packaged in a) 10-count tablets per box, NDC 41163-528-69, UPC 0 4116347138 2; and b) 30-count tablets per box, NDC 41163-528-31, UPC 0 4116346654 8; Distributed by: Supervalu Inc. Eden Prarie, MN  55344 USA", "product_quantity": "43,344 boxes", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "recall_initiation_date": "20150728", "center_classification_date": "20151015", "termination_date": "20161028", "report_date": "20151021", "code_info": "Batch Numbers:   a) 2617892, Exp 5/31/2016; 2625092, Exp 6/30/2016; 2544486, 2544488, Exp 7/31/2016; 2600127, Exp 2/29/2016; 2644265, Exp 9/30/2016    b) 2544486, 2544488, Exp 7/31/2016; 2600127, Exp 2/29/2016; 2644265, Exp 9/30/2016"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82748", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to Florida.", "recall_number": "D-1270-2019", "product_description": "Losartan Potassium/HCTZ, 100 mg/12.5 mg Tablet, 90-Count bottle, Manufactured by Torrent Pharmaceuticals, Distributed by RemedyRepack, Inc. Indiana, PA, 15701-3570, NDC 70518-1560-00.", "product_quantity": "44 HDPE bottles of 90 = 3,960 tablets", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.", "recall_initiation_date": "20190422", "center_classification_date": "20190502", "termination_date": "20200519", "report_date": "20190508", "code_info": "Lot #: B0517068-101618, Exp. Date: 10/2019"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1014-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 6%/Dextrose 10% with CALCIUM and HEPARIN, IV Bag, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0423-1", "product_quantity": "80 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251210, Exp. 7/10/2023; 36-254921, 36-254927, Exp. 7/22/2023."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71844", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1823-2015", "product_description": "Bupivacaine HCl 0.0625%, 250 mL total volume in a 250 mL LifeCare Bag in Sodium chloride 0.9%, Epidural Use Only, Rx Only, PharMEDium Services, LLC, 6100 Global Drive, Memphis, TN  36141, NDC# 61553-197-50", "product_quantity": "20 bags", "reason_for_recall": "Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).", "recall_initiation_date": "20150128", "center_classification_date": "20150923", "termination_date": "20170127", "report_date": "20150930", "code_info": "Lot #:  143140080M, Exp 02/09/15; 143210133M, Exp 02/16/15; 143490031M, Exp 03/16/15"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84396", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0576-2020", "product_description": "Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.", "product_quantity": "1,824 bottles", "reason_for_recall": "Presence of Foreign Substance: Presence of a foreign object in a single tablet.", "recall_initiation_date": "20191202", "center_classification_date": "20191206", "termination_date": "20211014", "report_date": "20191218", "code_info": "Lot #: NT119005A, Exp 07/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-029-2014", "product_description": "Adenosine Monophosphate, 50mg/ml 30ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "15 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62924", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "VA", "recall_number": "D-090-2013", "product_description": "Enjuvia (synthetic conjugated estrogens, B) tablets, 0.3mg, 30-count tablets per bottle, Rx only, Mfg. By: Duramed Pharmaceuticals, Pomona NY 10970; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK  74146; NDC 54868-6164-1.", "product_quantity": "5 bottles", "reason_for_recall": "Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.", "recall_initiation_date": "20110408", "center_classification_date": "20121211", "termination_date": "20130222", "report_date": "20121219", "code_info": "62QJ, Exp 12/11"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0309-2022", "product_description": "EPINEPHIrine in 0.9% Sodium Chloride Injection, 5 mg per 250 mL (20 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-052-01.", "product_quantity": "7548 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21255/BXA 22-Jan-22  S21264/BXH 29-Jan-22  S21328/BZO 10-Mar-22", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-456-2015", "product_description": "Truman Medical Center Lakewood (MO) Trophamine UAC Solution, Trophamine 3.2g, compound vol: 100 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "5 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74699, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74699-0-5-R, Disp ID: 37-1124574"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1248-2022", "product_description": "0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate), 45 mg/5 mL (9 mg/mL) syringes, packaged in 5 x 5 mL Prefilled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-947-50", "product_quantity": "1380 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: BL2007A, Exp. 7/3/2022"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66945", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-342-2014", "product_description": "Phenytoin Oral Suspension USP 125mg/5mL,  50 cups per case, For Oral Administration Only, Rx Only, Manufactured by: VistaPharm Inc, Largo, FL 33771, NDC 66689-036-50", "product_quantity": "27,788 cases", "reason_for_recall": "Defective Container: A lidding deformity allowed for the product to have out of specification results for assay and viscosity at the12 month stability timepoint.", "recall_initiation_date": "20131015", "center_classification_date": "20131206", "termination_date": "20160928", "report_date": "20131218", "code_info": "Lots #'s: 268200, Exp 06/14; 274600, Exp 08/14; 279500, Exp 09/14; 290700, Exp 12/14; 296700, Exp 02/15; 305100, Exp 06/15", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206251"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-278", "16729-279", "16729-280", "16729-281", "16729-282", "16729-283"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "402131", "602964"], "spl_id": ["40825d37-d601-2272-e063-6294a90af90d"], "spl_set_id": ["85cc7d25-414b-4b6f-a03a-48af908a16a1"], "package_ndc": ["16729-278-10", "16729-278-01", "16729-278-16", "16729-278-46", "16729-279-10", "16729-279-01", "16729-279-16", "16729-279-46", "16729-280-10", "16729-280-01", "16729-280-16", "16729-280-46", "16729-281-10", "16729-281-01", "16729-281-16", "16729-281-46", "16729-282-10", "16729-282-01", "16729-282-16", "16729-282-46", "16729-283-10", "16729-283-01", "16729-283-16", "16729-283-46"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"], "upc": ["316729279109", "316729279017"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0366-2023", "product_description": "Aripiprazole Tablets, USP 5 mg Rx Only, Packaged as a) 30-count bottle, NDC 16729-279-10, UPC 3 16729 27910 9; b) 100-count bottle, NDC 16729-279-01, UPC 3 16729 27901 7; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703.  Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. India", "product_quantity": "1,109,904 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2004259, P2004260, P2004261, Exp. Date 7/31/2023; P2006799, P2101391, Exp. Date 11/30/2023; P2100826, Exp. Date 1/31/2024; P2101320, Exp. Date 2/28/2024; P2102510, P2102409, P2102407, Exp. Date 3/31/2024; P2102410, Exp. Date 3/31/2024; P2105251, P2105252, P2105253, Exp. Date 7/31/2024; P2107404, P2107029, Exp. Date 10/31/2024; P2200260, P2200265, Exp. Date 12/31/2024; P2202067, P2202068, Exp. Date 3/31/2025; P2204239, Exp. Date 7/31/2025;  b) P2006800 Exp. Date 11/30/2023; P2102141, Exp. Date 3/31/2024; P2104085, Exp. Date 6/30/2024; P2107031, P2107466, Exp. Date 10/31/2024;", "more_code_info": ""}]